Blood Glucose Control

However, in 2016, Novo Nordisk halted the development of their basal oral insulin tablet.

Results from two studies demonstrate improved glycemic control, reduction in nighttime- and exercise-induced hypoglycemia with the use of hybrid closed-loop systems.

As we know, the most ineffective medication is the one needed but never taken. There are many reasons our patients don’t take prescription medicines, but a biggy is the cost. If a medicine is too expensive, the patient will not fill the prescription, therefore won’t take it. For example, when ordering an SGLT-2 and/or GLP-1, each can cost hundreds or more for a month’s prescription. Some are covered for both. Some are covered for one brand, but not the other.

Male, 62 years of age, type 2 diabetes, class III obesity. Has been on metformin, 1,000mg twice daily. Glucose in the 200-300mg/dL range. A1C. Taught about lower carb meal plan, started on Trulicity, first 0.75mg, then 1.5mg/dL. Made the dietary changes right away with the addition of the Trulicity. Within 2 weeks glucose levels averaged 125, patient losing weight, decreased appetite and feeling good. More energy. Insurance did not cover Trulicity, but did cover Victoza, so started on Victoza. When made the change, started with the 0.6mg daily, then increased weekly to the 1.8mg/day.

After 30 years of follow-up studies, DCCT/EDIC study gives findings regarding risk of severe hypoglycemia.

Glucose peaks tied to greater cognitive decline for those with diabetes and A1c ≥7.0 percent.

Study from Women's Health Initiative sought to determine whether low fasting glucose levels are associated with cardiovascular events and/or mortality.

12-year community-based cohort study investigated whether 1-h glucose concentration could be better indicator of diagnosis.

In part 7 of this Exclusive Interview, Michael Hill explains the education required to use the system.

Medication showed significant reduction in risk for cardiovascular death, hospitalization for worsening heart failure.